Medical devices, healthcare technology and the business of care
510(k) clearance · K254035

Mayumi Thrombectomy System

MicroVention, Inc., d/b/a Terumo Neuro · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK254035

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for the Mayumi™ Thrombectomy System, submitted by MicroVention, Inc., d/b/a Terumo Neuro, on September 3, 2026, under 510(k) K254035. The device is classified as an embolectomy catheter under 21 CFR 870.5150, Class II, with product codes QEZ and KRA, in the cardiovascular specialty. SESE means the device was cleared for marketing, not approved through a PMA. The summary lists K213402 (Triever24, Triever20) as the predicate.

The Mayumi system is a single-use, sterile, non-pyrogenic aspiration catheter set offered in 20Fr and 24Fr configurations, packaged with a dilator and Y-connector; the Y-connector is an addition relative to the predicate. The stated indications cover non-surgical removal of emboli and thrombi from blood vessels and injection, infusion or aspiration of fluids, limited to the peripheral vasculature. The summary states the submission does not claim pulmonary embolism treatment or clot-in-transit treatment in the right atrium. Bench testing listed includes device compatibility, physical attributes, aspiration suction volume and shaft performance; clinical outcome data are not described in the provided excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254035
Regulatory pathway
510(k) premarket notification
Product code
QEZ
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aspiration Thrombectomy Catheter.

Product code
QEZ
FDA device class
2

FDA decision timeline

  1. K254035 received

    Application receipt date recorded by FDA.

  2. K254035 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEZ

Product / regulatory recordCompanyPathwayDecision dateSource
Expanse Medical, Inc.510(k) clearanceOct 26, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

MicroVention, Inc., d/b/a Terumo Neuro

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Aliso Viejo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records